Aadi Bioscience rockets 72 percent on key updates
AADI Stock | USD 3.03 0.04 1.34% |
Under 55% of Aadi Bioscience's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that some traders are interested. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
Aadi |
Aadi Bioscience secures exclusive license agreement for Three-Asset ADC Portfolio and sells FYARRO for 100M, raising funds for operations.
Read at seekingalpha.com
Aadi Bioscience Fundamental Analysis
We analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Aadi Bioscience is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Aadi Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aadi Bioscience stock to make a market-neutral strategy. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics with similar companies.
Peers
Aadi Bioscience Related Equities
DSGN | Design Therapeutics | 6.37 | ||||
ADAG | Adagene | 5.00 | ||||
KURA | Kura Oncology | 4.45 | ||||
RARE | Ultragenyx | 4.45 | ||||
RZLT | Rezolute | 3.74 | ||||
ANAB | AnaptysBio | 2.78 | ||||
ERAS | Erasca | 1.58 | ||||
CRNX | Crinetics Pharmaceuticals | 1.42 | ||||
AVTE | Aerovate Therapeutics | 1.19 | ||||
MLYS | Mineralys Therapeutics, | 0.69 | ||||
RVMD | Revolution Medicines | 0.54 | ||||
GLUE | Monte Rosa | 0.54 | ||||
ANTX | AN2 Therapeutics | 0.79 | ||||
ACRV | Acrivon Therapeutics, | 0.88 | ||||
ANEB | Anebulo Pharmaceuticals | 1.86 | ||||
ARVN | Arvinas | 1.88 |
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |